Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Morand

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Analytical Chemistry|March 1, 2005
High-throughput solution-based medicinal library screening against human serum albuminJimmy Flarakos, Kenneth L Morand, Paul Vouros
Bulletin De L'Academie Nationale De Medecine|September 15, 1998
[Factors predictive of early virologic response after a first treatment with an protease inhibitor in the course of HIV infection]J Frottier, J L Meynard, L Morand-Joubert, et al.
Current Opinion in Drug Discovery & Development|March 20, 2002
Advances in high-throughput mass spectrometryK L Morand, T M Burt, B T Regg, et al.
Analytical Chemistry|February 24, 2001
Techniques for increasing the throughput of flow injection mass spectrometryK L Morand, T M Burt, B T Regg, et al.
Journal of Medical Virology|September 1, 1995
Serum anti-p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid-dissociated p24 antigenL Morand-Joubert, H Bludau, J Lerable, et al.
International Journal of Cancer|January 17, 1995
Correlation between viral DNA load and serum anti p19 antibody concentration in symptomless human T-lymphotropic virus type-I (HTLV-I)-infected individualsL Morand-Joubert, M Mariotti, D Reed, et al.
Journal of Acquired Immune Deficiency Syndromes|July 1, 1994
Predicting progression of HIV disease: usefulness of acid-dissociated p24 antigenL Morand-Joubert, D Costagliola, H Bludau, et al.
The Journal of Infectious Diseases|July 9, 1999
Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infectionJ J Lefrère, M Mariotti, L Morand-Joubert, et al.
Molecular and Cellular Probes|June 1, 1994
Analysis of BCR/ABL transcripts in chronic myeloid patients by nested PCR using an immunoassay-like detection formatV Barbu, B Alpha-Bazin, D Pepin, et al.
Analytical Chemistry|November 1, 2006
Comparison of LC/MS and SFC/MS for screening of a large and diverse library of pharmaceutically relevant compoundsJ David Pinkston, Dong Wen, Kenneth L Morand, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Analytical Chemistry|March 1, 2005
High-throughput solution-based medicinal library screening against human serum albuminJimmy Flarakos, Kenneth L Morand, Paul Vouros
Bulletin De L'Academie Nationale De Medecine|September 15, 1998
[Factors predictive of early virologic response after a first treatment with an protease inhibitor in the course of HIV infection]J Frottier, J L Meynard, L Morand-Joubert, et al.
Current Opinion in Drug Discovery & Development|March 20, 2002
Advances in high-throughput mass spectrometryK L Morand, T M Burt, B T Regg, et al.
Analytical Chemistry|February 24, 2001
Techniques for increasing the throughput of flow injection mass spectrometryK L Morand, T M Burt, B T Regg, et al.
Journal of Medical Virology|September 1, 1995
Serum anti-p24 antibody concentration has a predictive value on the decrease of CD4 lymphocyte count higher than acid-dissociated p24 antigenL Morand-Joubert, H Bludau, J Lerable, et al.
International Journal of Cancer|January 17, 1995
Correlation between viral DNA load and serum anti p19 antibody concentration in symptomless human T-lymphotropic virus type-I (HTLV-I)-infected individualsL Morand-Joubert, M Mariotti, D Reed, et al.
Journal of Acquired Immune Deficiency Syndromes|July 1, 1994
Predicting progression of HIV disease: usefulness of acid-dissociated p24 antigenL Morand-Joubert, D Costagliola, H Bludau, et al.
The Journal of Infectious Diseases|July 9, 1999
Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infectionJ J Lefrère, M Mariotti, L Morand-Joubert, et al.
Molecular and Cellular Probes|June 1, 1994
Analysis of BCR/ABL transcripts in chronic myeloid patients by nested PCR using an immunoassay-like detection formatV Barbu, B Alpha-Bazin, D Pepin, et al.
Analytical Chemistry|November 1, 2006
Comparison of LC/MS and SFC/MS for screening of a large and diverse library of pharmaceutically relevant compoundsJ David Pinkston, Dong Wen, Kenneth L Morand, et al.
Pageof 6